Angiogenesis
New angiogenesis study findings have been reported by scientists at MedImmune, Inc.
Published in Medical Device Business Week, January 17th, 2007
Scientists discuss in "Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin" new findings in angiogenesis. According to recent research from the United States, "The humanized monoclonal antibody Abegrin, currently in phase II trials for treatment of solid tumors, specifically recognizes the integrin alphavbeta3. Due to its high expression on mature osteoclasts, angiogenic endothelial cells, and tumor cells, integrin alphavbeta3 functions in several pathologic processes important to tumor growth and metastasis."
"Targeting of this integrin with Abegrin results in antitumor, antiangiogenic, and antiosteolytic activities. Here, we...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Adverse Drug Reaction
Bayer informs healthcare professionals of safety revisions to the Trasylol label - Awards
Biomatrica wins award for sample management at room temperature system - Awards
MedcomSoft ranked in top 5 for ambulatory EMR 1-5 physicians category in KLAS 2006 report - Awards
MedQuist product ranked first in front-end speech recognition in 2006 Best in KLAS report - Awards
Tgen researcher Pamela Pollock receives Young Investigator Award 2006 from melanoma society - Bacteriology
Berkeley Lab study finds over 1,800 types of bacteria in air samples from two U.S. cities - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
